By Grant J. Anhalt, M.D. and Hossein Nousari, M.D.Johns Hopkins University, School of Medicine In February 1997, the FDA approved a new drug, mycophenolate mofetil (MFM, also known as Cellcept) with an approved indication for use in immunosuppression of patients…
- Accueil
- Qui sommes-nous
- Vivant avec P/P
- Recherche
- Impliquez-vous
- Actualités & Info
- Forums de discussion
